Your browser doesn't support javascript.
loading
Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
Gao, Na; Wang, Xue-Xia; Sun, Jian-Rong; Yu, Wen-Zheng; Li, Xi-Zhi.
  • Gao N; Department of hematology, Binzhou Medical University Hospital, Binzhou, Shandong, China. gn2882155@163.com.
  • Wang XX; Department of hematology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Sun JR; Department of hematology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Yu WZ; Department of hematology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Li XZ; Department of nephrology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Ann Hematol ; 96(5): 711-718, 2017 May.
Article en En | MEDLINE | ID: mdl-28238096

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda / Proteínas de Fusión Oncogénica / Galectina 3 Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda / Proteínas de Fusión Oncogénica / Galectina 3 Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article